CRP and type 2 diabetes mellitus: This novel biomarker has been shown in multiple cohorts of older individuals to predict the future development of both type 2 diabetes and CVD independently of CRP,15, 16 suggesting that it may capture different upstream inflammatory pathways relevant to both diseases.